Overview

Twelve Month Follow-Up of CP0108

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the long-term safety and efficacy of Levulan PDT in subjects with multiple actinic keratosis of the upper extremities who received treatment as part of the DUSA CP0108 study.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
DUSA Pharmaceuticals, Inc.
Treatments:
Aminolevulinic Acid
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Subject must have been enrolled in the DUSA-CP0108 study, completed their assigned
treatment and Visit 6 (Week 12).